<ul>
 <li>Autosomal recessive inheritance</li>
 <li>Carnitine shuttle</li>
  <li>Newborn screening</li>
  <li>Clinical features</li>
</ul>

Autosomal recessive inheritance Carnitine shuttle Newborn screening Clinical features

Understanding LC-FAODs

Patients with long-chain fatty oxidation disorders (LC-FAODs) have historically been treated with diet modification and even-carbon medium-chain triglyceride (MCT) supplementation. In this 45-minute, case-based, modular activity, Sandra van Calcar, PhD, RD, LD, and Jerry Vockley, MD, PhD, address key topics, including disease presentation, historical treatment, emerging treatment with triheptanoin, and nutritional planning specific to patients with LC-FAODs.

Share Understanding LC-FAODs

Sign up to save your podcasts

Understanding LC-FAODs

Understanding LC-FAODs